Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0X7HM
|
||||
| Former ID |
DAP000535
|
||||
| Drug Name |
Carboplatin
|
||||
| Synonyms |
Azanide; Carbopaltin; Carboplatine; Carboplatino; Carboplatinum; Cbdca; Ercar; Paraplatin; Carboplatine [French]; Carboplatino [Spanish]; Carboplatinum [Latin]; C 2538; JM 8; Carboplatin (USAN); IUPAC: Azane; JM-8; Paraplatin (TN); Paraplatin, Carboplatin; Paraplatin-AQ; Cis-Diammine(cyclobutanedicarboxylato)platinumII; Platinum(+2) Cation; Platinum(2+); Carboplatin (JAN/USP/INN); Carboplatin [USAN:INN:BAN:JAN]; Cyclobutane-1,1-dicarboxylate; Cyclobutane-1,1-dicarboxylic acid; Diammine-1,1-cyclobutane dicarboxylate platinum II; Cis-Diamine[1,1-cyclobutanedicarboxylato]platinum(II); Cis-Diammine(1,1-cyclobutanedicarboxylato) platinum; Cis-Diammine(1,1-cyclobutanedicarboxylato)platinum; Cis-Diammine[1,1-cyclobutane-dicarboxylato] platinum; Diammine(1,1-cyclobutanedicarboxylato)platinum (II); Platinum, {diammine[1,1-cyclobut; Cis-(1,1-Cyclobutanedicarboxylato)diammineplatinum(II); Cis-Diamine(1,1-cyclobutanedicarboxylato)platinum(II); Cis-Diammine(1,1-cyclobutanedicarboxylato)platinum(II); Platinum(II), (1, 1-cyclobutanedicar; Diammine[cyclobutane-1,1-dicarboxylato(2-)-k2O1,O1]platinum; Diammine(cyclobutane-1,1-dicarboxylato(2-)-O,O')platinum; Platinum, diammine(1,1-cyclobutanedicarboxylato(2-)-O,O')-, (SP-4-2); (SP-4-2)-diammine[cyclobutane-1,1-dicarboxylato(2-)-kappa(2)O,O']platinum; 1,1-Cyclobutanedicarboxylate diammine platinum (II); 1,1-Cyclobutanedicarboxylate diammine platinum(II)
|
||||
| Drug Type |
Small molecular drug
|
||||
| Therapeutic Class |
Anticancer Agents
|
||||
| Company |
Bristol-Myers Squibb
|
||||
| Structure |
|
Download2D MOL |
|||
| Formula |
C6H12N2O4Pt
|
||||
| CAS Number |
CAS 41575-94-4
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID |
15350457, 22704376, 33972238, 75354552, 87558792, 117682520, 127293893, 127293894, 127293895, 127293896, 127293897, 127293898, 127293899, 127293900, 127293901, 127293902, 127293903, 127293904, 127293905, 127293906, 127293907, 127293908, 127293909, 127293910, 127293911, 127293912, 127293913, 127293914, 127293915, 127293916, 127293917, 127293918, 127293919, 127293920, 127293921, 127293922, 127293923, 127293924, 127293925, 127293926, 127293927, 127293928, 127293929, 127293930, 127293931, 127293932, 127293933, 127293934, 127293935, 127293936
|
||||
| ChEBI ID |
ChEBI:31355
|
||||
| SuperDrug ATC ID |
L01XA02
|
||||
| SuperDrug CAS ID |
cas=041575944
|
||||
| Target and Pathway | |||||
| Target(s) | Human DNA | Target Info | Modulator | ||
| References | |||||
| Ref 538307 | FDA Approved Drug Products from FDA Official Website. 2009. Application Number: (ANDA) 076039. | ||||
| Ref 542611 | (http://www.guidetopharmacology.org/) Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 7624). | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.